483
Avadel CNS Pharmaceuticals LLCAvadel CNS Pharmaceuticals LLC – FDA 483, Sep 12, 2025
Record Details
Avadel CNS Pharmaceuticals LLC, located in Chesterfield, MO, was inspected regarding its Risk Evaluation and Mitigation Strategy (REMS) program. The inspection revealed that the firm failed to comply with its approved REMS audit plan and schedule. Specifically, several certified pharmacies were audited outside the required 90-day initial timeframe or the annual audit timeframe for the drug Lumryz.
View Company Profile
ID · 463e5c07-8816-4d91-a81e-150cf522a6db
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.